Bacteriophage Therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abdul-Hassan H. S. El-Tahan E. Massoud B. Gomaa R. Bacteriophage therapy of pseudomonas burn wound sepsis. Ann. Medit. Burn Club 3 1990 262 264
Adamia R. S. Matitashvili E. A. Kvachadze L. I. Korinteli V. I. Matoyan D. A. Kutateladze M. I. Chanishvili T. G. The virulent bacteriophage IRA of Salmonella typhimurium: cloning of phage genes which are potentially lethal for the host cell. J. Basic Microbiol. 10 1990 707 716
Andriashvili I. A. Kvachadze L. I. Vashakidze R. P. Adamia R. S. Chanishvili T. G. Molecular mechanisms of DNA protection from restriction endonucleases in Staphylococcus aureus cells. Mol. Gen. Mikrobiol. Virusolol. 8 1986 43 45
Anonymous Phage therapy. Lancet iii 1983 1287 1288
Anpilov L. I. Prokudin A. A. Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective groups. Voenno-Med. Zh. 5 1984 39 40
Babalova E. G. Katsitadze K. T. Sakvarelidze L. A. Imnaishvili N. S. Sharashidze T. G. Badashvili V. A. Kiknadze G. P. Meipariani A. N. Gendzekhadze N. D. Machavariani E. V. Gogoberidze K. L. Gozalov E. I. Dekanosidze N. G. Preventive value of dried dysentery bacteriophage. Zh. Mikrobiol. Epidemiol. Immunobiol. 2 1968 143 145
Barrow P. A. Soothill J. S. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 7 1997 268 271
Bogovazova G. G. Voroshilova N. N. Bondarenko V. M. The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection. Zh. Mikrobiol. Epidemiol. Immunobiol. 4 1991 5 8
Bogovazova G. G. Voroshilova N. N. Bondarenko V. M. Gorbatkova G. A. Afanas'eva E. V. Kazakova T. B. Smirnov V. D. Mamleeva A. G. Glukharev I. A. Erastova E. I. Krylov I. A. Ovcherenko T. M. Baturo A. P. Yalsyk G. V. Arefyeva N. A. Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages. Zh. Mikrobiol. Epidemiol. Immunobiol. 3 1992 30 33
Bordet J. Ciuca M. Remarques sur l'historique de recherches concernant la lyse microbienne transmissible. Compt. Rend. Soc. Biol. 84 1921 745 747
Bruynoghe R. Maisin J. Essais de thérapeutique au moyen du bacteriophage. C. R. Soc. Biol. 85 1921 1120 1121
Carlton R. M. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 5 1999 267 274
Chernomordik A. B. Bacteriophages and their therapeutic-prophylactic use. Med. Sestra 6 1989 44 47
Cislo M. Dabrowski M. Weber-Dabrowska B. Woyton A. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 2 1987 175 183
D'Herelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. (Paris) 165 1917 373 375
Eaton M. D. Bayne-Jones S. Bacteriophage therapy. Review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA 23 1934 1769 1939
Hankin E. H. L'action bactericide des eaux de la Jumna et du Gange sur le vibrion du cholera. Ann. Inst. Pasteur 10 1896 511
Ioseliani G. D. Meladze G. D. Chkhetiia N. S. Mebuke M. G. Kiknadze N. I. Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Grudn. Khir. 6 1980 63 67
Kaczkowski H. Weber-Dabrowska B. Dabrowski M. Zdrojewicz Z. Cwioro F. Use of bacteriophages in the treatment of chronic bacterial diseases. Wiad. Lek. 43 1990 136 141
Kiknadze G. P. Gadua M. M. Tsereteli E. V. Mchedlidze L. S. Birkadze T. V. Efficiency of preventive treatment by phage preparations of children's hospital salmonellosis Intestinal infections. Kiknadze G. P. 1986 41 44 Sovetskaya Meditsina Tbilisi Georgia
Kochetkova V. A. Mamontov A. S. Moskovtseva R. L. Erastova E. I. Trofimov E. I. Popov M. I. Dzhubalieva S. K. Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms. Sov. Med. 6 1989 23 26
Krueger A. P. Scribner E. J. Bacteriophage therapy. II. The bacteriophage: its nature and its therapeutic use. JAMA 19 1941 2160 2277
Kucharewicz-Krukowska A. Slopek S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 5 1987 553 561
Kutter E. Guttman B. Carlson K. The transition from host to phage metabolism after T4 infection Molecular biology of bacteriophage T4. Karam J. D. 1994 343 346 American Society for Microbiology Washington D.C.
Kwarcinski W. Lazarkiewicz B. Weber-Dabrowska B. Rudnicki J. Kaminski K. Sciebura M. Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection. Pol. Tyg. Lek. 49 1994 535
Lang G. Kehr P. Mathevon H. Clavert J. M. Sejourne P. Pointu J. Bacteriophage therapy of septic complications of orthopaedic surgery. Rev. Chir. Orthop. Reparatrice Appar. Mot. 1 1979 33 37
Litvinova A. M. Chtetsova V. M. Kavtreva I. G. Evaluation of efficacy of the use of E. coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants. Vopr. Okhr. Materin. Det. 9 1978 42 44
Meladze G. D. Mebuke M. G. Chkhetia N. S. Kiknadze N. I. Koguashvili G. G. Timoshuk I. I. Larionova N. G. Vasadze G. K. The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura. Grudn. Khir. 1 1982 53 56
Merril C. R. Biswas B. Carlton R. Jensen N. C. Creed G. J. Zullo S. Adhya S. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 8 1996 3188 3192
Miliutina L. N. Vorotyntseva N. V. Current strategy and tactics of etiotropic therapy of acute intestinal infections in children. Antibiot. Khimioter. 1 1993 46 53
Ochs H. D. Buckley R. H. Kobayashi R. H. Kobayashi A. L. Sorensen R. U. Douglas S. D. Hamilton B. L. Hershfield M. S. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood 5 1992 1163 1171
Ochs H. D. Nonoyama S. Zhu Q. Farrington M. Wedgewood R. J. Regulation of antibody responses: the role of complement and adhesion molecules. Clin. Immunol. Immunopathol. 67 1993 S33 S40
Pavlenishvili I. Tsertsvadze T. Bacteriophagotherapy and enterosorbtion in treatment of sepsis of newborns caused by gram-negative bacteria. Pren. Neon. Infect. 11 1993 104
Peremitina L. D. Berillo E. A. Khvoles A. G. Experience in the therapeutic use of bacteriophage preparations in suppurative surgical infections. Zh. Mikrobiol. Epidemiol. Immunobiol. 9 1981 109 110
Perepanova T. S. Darbeeva O. S. Kotliarova G. A. Kondrat'eva E. M. Maiskaia L. M. Malysheva V. F. Baiguzina F. A. Grishkova N. V. The efficacy of bacteriophage preparations in treating inflammatory urologic diseases. Urol. Nefrol. 5 1995 14 17
Pokrovskaya M. P. Kaganova L. C. Morosenko M. A. Bulgakova A. G. Skatsenko E. E. Treatment of wounds with bacteriophages 2nd ed. 1942 State Publishing House “Medgiz ” Moscow USSR
Proskurov V. A. Use of staphylococcal bacteriophage for therapeutic and preventive purposes. Zh. Mikrobiol. Epidemiol. Immunobiol. 2 1970 104 107
Sakandelidze V. M. Meipariani A. N. Use of combined phages in suppurative-inflammatory diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 6 1974 135 136
Sakandelidze V. M. The combined use of specific phages and antibiotics in different infectious allergoses. Vrach. Delo 3 1991 60 63
Samsygina G. A. Boni E. G. Bacteriophages and phage therapy in pediatric practice. Pediatria 4 1984 67 70
Schless R. A. Staphylococcus aureus meningitis: treatment with specific bacteriophage. Am. J. Dis. Child. 44 1932 813 822
Shabalova I. A. Karpanov N. I. Krylov V. N. Sharibjanova T. O. Akhverdijan V. Z. Pseudomonas aeruginosa bacteriophage in treatment of P. aeruginosa infection in cystic fibrosis patients Proceedings of IX International Cystic Fibrosis Congress. 1995 443 International Cystic Fibrosis Association Zurich Switzerland
Slopek S. Durlakowa I. Weber-Dabrowska B. Kucharewicz-Krukowska A. Dabrowski M. Bisikiewicz R. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. 31 1983 267 291
Slopek S. Durlakowa I. Weber-Dabrowska B. Kucharewicz-Krukowska A. Dabrowski M. Bisikiewicz R. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp. 31 1983 293 327
Slopek S. Durlakowa I. Weber-Dabrowska B. Dabrowski M. Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in a further 150 cases. Arch. Immunol. Ther. Exp. 32 1984 317 335
Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp. 33 1985 219 240
Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch. Immunol. Ther. Exp. 33 1985 241 259
Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. 33 1985 261 273
Slopek S. Weber-Dabrowska B. Dabrowski M. Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch. Immunol. Ther. Exp. 35 1987 569 583
Smith H. W. Huggins M. B. Successful treatment of experimental Escherichia coli infections in mice using phages: its general superiority over antibiotics. J. Gen. Microbiol. 128 1982 307 318
Smith H. W. Huggins M. B. Effectiveness of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129 1983 2659 2675
Smith H. W. Huggins M. B. The control of experimental E. coli diarrhea in calves by means of bacteriophage. J. Gen. Microbiol. 133 1987 1111 1126
Smith H. W. Huggins M. B. Shaw K. M. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J. Gen. Microbiol. 133 1987 1127 1135
Soothill J. S. Lawrence J. C. Ayliffe G. A. J. The efficacy of phages in the prevention of the destruction of pig skin in vitro by Pseudomonas aeruginosa. Med. Sci. Res. 16 1988 1287 1288
Stout B. F. Bacteriophage therapy. Texas State J. Med. 29 1933 205 209
Stroj L. Weber-Dabrowska B. Partyka K. Mulczyk M. Wojcik M. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol. Neurochir. Pol. 3 1999 693 698
Summers W. C. Felix d'Herelle and the origins of molecular biology. 1999 Yale University Press New Haven Conn
Tolkacheva T. V. Abakumov E. M. Martynova V. A. Golosova T. V. Correction of intestinal dysbacteriosis with biological preparations in acute leukemia. Probl. Gematol. Pereliv. Krovi 7 1981 29 33
Twort F. W. Researches on dysentery. Br. J. Exp. Pathol. 1 1920 237 243
Van Helvoort T. Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon. Med. Hist. 3 1992 243 270
Vieu J. F. Guillermet F. Minck R. Nicolle P. Donnees actuelles sur les applications therapeutiques des bacteriophages. Bull. Acad. Natl. Med. 163 1979 61
Weber-Dabrowska B. Dabrowski M. Slopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35 1987 563 568
Weber-Dabrowska B. Zimecki M. Mulczyk M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48 2000 31 37
Yao J. D. C. Moellering R. C. Jr. Antimicrobial agents Manual of clinical microbiology 7th ed. Murray P. R. Baron E. J. Pfaller M. A. Tenover F. C. Yolken R. H. 1995 1474 1504 American Society for Microbiology Washington D.C.
Zhukov-Verezhnikov N. N. Peremitina L. D. Berillo E. A. Komissarov V. P. Bardymov V. M. Khvoles A. G. Ugryumov L. B. A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases. Sov. Med. 12 1978 64 66